Pro Basketball League Allows Players To Use CBD Despite

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
310
Pro Basketball League Allows Players To Use CBD Despite Federal Prohibition

https://www.naturalblaze.com/2018/08/pro-bask...ition.html

arlier this summer, Big3 basketball became the first professional sports league to allow its players to use cannabidiol (CBD). This represents another step toward nullifying federal hemp prohibition in practice and effect.

CBD is derived from cannabis, but since it’s generally processed from industrial hemp, it does not contain high levels of THC – the active ingredient in marijuana that makes people high. It’s proven effective in treating a number of medical conditions, including seizures, pain, inflammation and anxiety.

In June, Big3 announced it would allow its athletes to use CBD for pain management and recovery.

“Despite many states around the country making efforts to decriminalize or legalize cannabis, both medicinally and recreationally, professional athletes who could benefit medicinally are prevented from doing so by league outdated mandates,” the league said in a statement. “More than a dozen countries, including Canada and Israel, have approved CBD-based medications for both professional athletes and consumers … In the U.S., the shift is beginning to happen as the medication is not only used for pain management, but preferred over the powerfully addictive opioids and pain-relief drugs that are often the only other option.’’

You can buy CBD products over the counter in many states. As a result, people mistakenly believe CBD is legal. In fact, many mainstream articles claim it is “legal in all 50 states.” But the federal government begs to differ. In fact, the DEA considers CBD a schedule 1 drug, and as such, generally illegal across the country.

A drug called Epidiolex approved by the FDA June 27, 2018, to treat seizures in a rare form of epilepsy is the only CBD product federally-legal, and then only with a prescription.

People in the cannabis industry who argue that CBD is legal over the counter rely on the “hemp amendment” in the 2014 farm bill. But the law only legalized hemp production for limited purposes. It “allows State Agriculture Departments, colleges and universities to grow hemp, defined as the non-drug oilseed and fiber varieties of Cannabis, for academic or agricultural research purposes, but it applies only to states where industrial hemp farming is already legal under state law.”

In 2016, the U.S. Department of Agriculture and Drug Enforcement Agency released a “statement of principles” to guide interpretation of the hemp section in the Farm Bill. It states, “The growth and cultivation of industrial hemp may only take place in accordance with an agricultural pilot program to study the growth, cultivation, or marketing of industrial hemp established by a State department of agriculture or State agency responsible for agriculture in a State where the production of industrial hemp is otherwise legal under State law.”

In short, the current federal law authorizes farming of hemp – by research institutions, or within state pilot programs – for research only. Farming for commercial purposes by individuals and businesses remains prohibited.

The definition of “commercial” remains murky and has created significant confusion.

The statement of principles also asserted that industrial hemp programs are limited to fiber and seed. It didn’t mention CBD oil or other edible hemp products. The DEA has interpreted that to mean they remain illegal. According to the DEA, CBD cannot be sold under any circumstances.

An Indiana TV station interviewed DEA spokesman Rusty Payne.

It’s not legal. It’s just not.

Payne says cannabis plants are considered a Schedule I controlled substance, and medicinal oils derived from cannabis plants are illegal according to two federal laws: the Controlled Substance Act and the Food, Drug and Cosmetic Act. He said confusion surrounding the Agricultural Act of 2014 (better known as the “Farm Bill”) is frequently cited as legal justification by those who want to manufacture, sell or use CBD oil. The DEA believes the Farm Bill permits only CBD research — not CBD marketing and sales.

“Anybody who’s in violation [of the federal laws] always runs that risk of arrest and prosecution,” he said.

Nevertheless, people across the country are selling, buying and using CBD, and nullifying the federal law in practice and effect. The Big3’s decision to allow players to use CBD takes another step toward mainstreaming it and further undermines federal prohibition efforts.

Other sports leagues may follow suit. According to a report in Forbes, pro hockey might be next in line. The NHL has traditionally been lenient on cannabis use.

Hockey has never necessarily been willing to openly condone cannabis use, though, until last month. National Hockey League Players’ Association (NHLPA) executive director Don Fehrs said it’s ‘possible that the NHL and NHLPA could come to an informal understanding about marijuana usage among players in the League in the future.’

This demonstrates an important truth. When people begin to recognize the benefits of a substance and markets begin to develop, nobody cares much what the federal government says.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Netcapital Faces Legal Storm: Class Action Alert

Updated Category News Views 43

Litigation Clouds Hover Over Netcapital Every seasoned investor knows, when there's smoke, there's usually fire lurking somewhere. And boy, oh boy, is Netcapital Inc. (NASDAQ: NCPL) currently engulfed in quite a storm of controversy. This isn't your run-of-the-mill market hiccup — we're talking about a full-blown class action lawsuit sailing through the courts, with...

Continue Reading
ResMed Faces Probe: Potential Breach Alert for Investors

Updated Category News Views 57

Cracks Surfacing at ResMed? Alright, folks, ResMed Inc. (NYSE: RMD) is facing a bit of heat these days. We're talking about a shareholder alert as Levi & Korsinsky, noted legal hounds when it comes to financial misconduct, have decided to dig deep into ResMed. They're looking to uncover any possible breaches of fiduciary duties by some of the top brass at this sleep apnea...

Continue Reading
Pomifera's Holiday Skincare Sets: A Gift of Glow

Updated Category News Views 38

Unwrapping Pomifera's Holiday Magic When it comes to holiday gifts, nothing says 'I care' like a touch of skincare magic, and Pomifera's got your back. The brand, known for its signature Pomifera Oil, is turning the art of gifting into an indulgence with three curated collections. These ain't your run-of-the-mill lotions and potions. We're talking about products that...

Continue Reading
LASEROPTEK Embraces CPT Clarity: Impacts on Dermatology

Updated Category News Views 61

CPT Changes: A New Era for Dermatology? Get this: the American Medical Association's revisions to the CPT codes could be just the spark LASEROPTEK's been waiting for. Landing on the desk is the 2027 Current Procedural Terminology (CPT) code set which clarifies how docs report targeted UVB laser treatments. We're talking about codes 96920–96922, now clear as crystal,...

Continue Reading
Simtra Invests $250M in Major Expansion at Bloomington

Updated Category News Views 136

Simtra BioPharma's Big Leap Forward Simtra BioPharma Solutions is making waves with their hefty $250 million investment, debuting their substantial expansion in Bloomington, Indiana. Building H isn't just another upgrade; it's a key piece in their ambitious strategy to bolster their sterile injectable manufacturing capacity. Lovers of big biotech moves, this one's worth...

Continue Reading
Greenberg Traurig Shareholders Earn Law360 MVP Honors

Updated Category News Views 21

A Spotlight on Legal Excellence In the tough-as-nails world of legal battles, a select few rise above the rest, but it's not every day you see three folks from the same shop getting the nod as MVPs. That's the story coming out of Greenberg Traurig, where shareholders Gregory A. Fishman, Michael J. Thomas, and David B. Weinstein made the cut for the 2026 Law360 MVP honors....

Continue Reading
Global Museum of Illusions Comes to San Francisco

Updated Category News Views 196

Illusions on Market Street The Global Museum of Illusions, the fast-growing sensation in private museums, is setting its sights on San Francisco with a new location opening on Market Street this November 13. They're dangling a juicy 50% off presale ticket offer for the early birds. A Mind-Bending Experience This museum isn't your run-of-the-mill art gallery or historical...

Continue Reading
From Vätternrundan to Göta Canal: Circularity in Action

Updated Category News Views 28

Sustainability in Action: Vätternrundan Leads the Way Ever thought your banana peel could contribute to cultural heritage? That’s the twist here. Vätternrundan 2026 hit the mark by turning food waste into a natural asset along the Göta Canal. It's a glimpse of the future where waste isn't a by-product but a resource. Transforming Waste into Growth In a world where...

Continue Reading
Krispy Kreme Faces Legal Heat Post McDonald's Exit

Updated Category News Views 110

Krispy Kreme's Sugar-Coated Trouble Ah, Krispy Kreme, where donuts and legal woes seem to go hand in hand these days. Dropping donuts might be a morning mishap, but dropping a stock by 37%? Now that’s a disaster, especially when folks like Schubert Jonckheer & Kolbe smell a rat in the kitchen. Fresh Out of the Baker's Oven: Lawsuit Updates On August 26, 2026, a...

Continue Reading
Tigermed's Strategic Shift: Privatization and Divestment

Updated Category News Views 6

Hang onto your hats, folks, because Tigermed is shaking things up in a big way. The Chinese juggernaut you might know as Hangzhou Tigermed Consulting Co., Ltd. is throwing its hat in the ring for the privatization of Frontage Holdings. But that's not the end of the story—there's a whole restructuring circus coming to town, and they've got big plans to offload some...

Continue Reading

Top 5 Most Recently Viewed Articles

CESI Launches Solar Cell Production Line and Space Division

Updated Category News Views 373

CESI Strengthens Leadership in Space Energy CESI has made significant strides in the space energy sector by inaugurating a cutting-edge solar cell production line at its laboratories. This development is accompanied by the launch of CESI Space, a newly established business unit focused exclusively on the space domain. Investment and Expansion in Technology The company has...

Continue Reading
Auburn National Bancorporation Sees Income Growth in Q3

Updated Category News Views 142

Third Quarter Highlights of Auburn National Bancorporation Key Financial Performances The recent financial report from Auburn National Bancorporation reveals a positive trend for the third quarter of 2025. The company has reported a significant increase in its net earnings, totaling $2.2 million, which translates to $0.64 per share. This is an increment from the previous...

Continue Reading
Aura Minerals Inc. Announces Key Leadership Changes

Updated Category Stocks Views 838

Leadership and Management Structure Updates at Aura Minerals Inc. Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF), has revealed changes in its management and leadership system. These developments seek to maximize processes and enhance the leadership team of the business so as to satisfy strategic objectives. Experienced experts brought into important roles by...

Continue Reading
Praxis Tech Unveils Cutting-Edge AI Smart Routing Feature

Updated Category News Views 215

Praxis Tech Launches Innovative AI Smart Routing Tool Praxis Tech has unveiled an exciting new feature called AI Smart Routing, designed to enhance payment success rates for merchants. This advanced tool leverages artificial intelligence to analyze payment patterns and propose optimal strategies for routing transactions effectively. By doing so, it significantly improves...

Continue Reading
Future Growth and Innovations in Interventional Cardiology Devices

Updated Category News Views 334

Interventional Cardiology Devices Market Overview The interventional cardiology devices market is on an impressive upward trajectory, poised to reach a valuation of approximately US$ 30.23 billion by 2033. This growth from 16.89 billion in 2024 indicates a robust compound annual growth rate (CAGR) of around 7.55% during the forecast period. The increasing prevalence of...

Continue Reading